Evidence map›Paper›PMID 40055208›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

Clinical comprehensive evaluation of [

Ziqi Zhang, Shaoyu Liu, Sihao Liang, Xuejing Bai, Yulu He, Jiawei Zhong, Wanmei Liang, Peng Hou, Huizhen Zhong, Tingfan Wu and 5 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Clinical Evaluation of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. FAP Expression in Renal Tumors Assessed by [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ziqi Zhang *Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Shaoyu Liu *Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Sihao Liang *Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Xuejing BaiDepartment of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Yulu HeDepartment of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Jiawei ZhongDepartment of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Wanmei LiangDepartment of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Peng HouDepartment of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Huizhen ZhongDepartment of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Tingfan WuUnited Imaging Research Institute, United Imaging Healthcare Group Co., Ltd, Shanghai, 201807, China.
Yee Ling NgUnited Imaging Research Institute, United Imaging Healthcare Group Co., Ltd, Shanghai, 201807, China.
Jing ZhangDepartment of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Miao KeDepartment of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Yimin FuDepartment of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China.
Xinlu WangDepartment of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China. 71lu@163.com.ORCID 0000-0003-1997-5687

Funding

Applied and Basic Research Foundation of Guangdong Province 2020A1515110159National Natural Science Foundation of China 82001879Science and Technology Project of Guangzhou City 202102010354Science and Technology Project of Guangzhou City 202201020558Science and Technology Project of Guangzhou City 2024A03J1080Zhongnanshan Medical Foundation of Guangdong Province ZNSA-2020003
6 · The paper itself

Abstract

purposeThis study was designed to investigate the clinical feasibility of [

methodsTen patients participated in a multi-time-point imaging protocol aimed at assessing pharmacokinetics and estimating radiation dosimetry. Radiation dosimetry calculations were performed using the OLINDA/EXM 2.0 software. For the comparative analysis between [

resultsThe study of multi-time-point imaging demonstrated that tumor SUV

conclusionOur pilot study in patients with various solid tumors has demonstrated acceptable radiation dosimetry, favorable biodistribution, and significant [

Indexed as

Fluorodeoxyglucose F18NeoplasmsPositron Emission Tomography Computed TomographyAdultAgedFemaleHumansMaleMiddle AgedRadiometryRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals18F-labeledFibroblast activation proteinPathologicalPositron emission tomographyStandardized uptake values

Identifiers

PMID40055208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.